1e
19
1
49
2
2
18
1b
1d
18
3f
79
1d
2 29
1d
25
Anna Elizabeth Kersh, M.D., Ph.D.
88
79
Assistant Professor of Dermatology at the Hospital of the University of Pennsylvania
7
62
Department: Dermatology
4
1
b
1d
46
Contact information
49
4
3
3
3
2
4
b
1f
49
3400 Civic Center Boulevard
2d Perelman Center for Advanced Medicine
39 7th Floor South - #769
Philadelphia, PA 19104
26
2d Perelman Center for Advanced Medicine
39 7th Floor South - #769
Philadelphia, PA 19104
35
a3
12
13
Education:
21 9 B.A. c
33 University of Pennsylvania, 2009.
21 a Ph.D. 30 (Immunology & Molecular Pathogenesis) c
29 Emory University, 2015.
21 9 M.D. c
29 Emory University, 2017.
c
3
3
21
21 9 B.A. c
33 University of Pennsylvania, 2009.
21 a Ph.D. 30 (Immunology & Molecular Pathogenesis) c
29 Emory University, 2015.
21 9 M.D. c
29 Emory University, 2017.
c
1f
Post-Graduate Training
24 5b Intern in Medicine, Kettering Medical Center, Kettering, Ohio, 2017-2018.
24 3b Resident in Dermatology, Hospital of the University of 43 Pennsylvania, Philadelphia, Pennsylvania, 2018-2021.
24 37 Post-Doctoral Fellow, Dr. Thomas Leung Laboratory, 51 University of Pennsylvania, Philadelphia, Pennsylvania, 2020-2023.
c
3
25
24 5b Intern in Medicine, Kettering Medical Center, Kettering, Ohio, 2017-2018.
24 3b Resident in Dermatology, Hospital of the University of 43 Pennsylvania, Philadelphia, Pennsylvania, 2018-2021.
24 37 Post-Doctoral Fellow, Dr. Thomas Leung Laboratory, 51 University of Pennsylvania, Philadelphia, Pennsylvania, 2020-2023.
c
17
Certifications
28 36 American Board of Dermatology, 2021.
c
3
8d
Permanent link28 36 American Board of Dermatology, 2021.
c
2 29
21
1e
1d
24
2b
29
27
23
134 Huang J, Sati S, Murphy C, Spencer CA, Rapp E, Prouty SM, Korte S, Ahart O, Sheng E, Jones P, Kersh AE, Leung D, Leung TH.: Granulocyte colony stimulating factor promotes scarless tissue regeneration. Cell Rep 43(10): 114742, Oct 2024.
100 Kersh AE, Sati S, Huang J, Murphy C, Ahart O, Leung TH.: CXCL9, CXCL10, and CCL19 synergistically recruit T lymphocytes to skin in lichen planus. JCI Insight 9(20): e179899, Oct 2024.
177 Sati S, Huang J, Kersh AE, Jones P, Ahart O, Murphy C, Prouty SM, Hedberg ML, Jain V, Gregory SG, Leung DH, Seykora JT, Rosenbach M, Leung TH.: Recruitment of CXCR4+ type 1 innate lymphoid cells distinguishes sarcoidosis from other skin granulomatous diseases. J Clin Invest 134(17): e178711, Sep 2024.
130 Bhattarcharya, S., Sheng, E., Murphy, C., Wei, J., Kersh, A.E., Nelson, C.A., Aschanyan, H.A., Steele, K., Forrestel, A., Seykora, J.T., Micheletti, R.G., James, W.D., Rosenbach, M., Leung, T.H. : Identification of a neutrophil-specific PIK3R1 mutation 33 facilitates targeted treatment in a patient with 50 Sweet syndrome. J Clin Invest 133(1): e162137, Jan 2023.
199 Bhattacharya S, Basu S, Sheng E, Murphy C, Wei J, Kersh AE, Nelson CA, Bryer JS, Ashchyan HA, Steele K, Forrestel A, Seykora JT, Micheletti RG, James WD, Rosenbach M, Leung TH.: Identification of a neutrophil-specific PIK3R1 mutation facilitates targeted treatment in a patient with Sweet syndrome. J Clin Invest 133: e162137, Jan 2023.
14c Abbott JJ, Jiang AJ, Rauck C, Frank DM, Fortuna D, Kersh A, Rubin AI.: Cutaneous metastatic gastric carcinoma with plasmacytoid features: A novel histopathologic pitfall in the diagnosis of primary cutaneous plasmacytoma. J Cutan Pathol 50(1): 8-11, Jan 2023.
ee Torre EA, Kersh AE, Fischer AS, Xu X, Rosenbach M, Shields BE.: Angiokeratoma-like purpuric palmar nodules following chemotherapy. Dermatol Online J 27(8), Aug 2021.
fd Kersh AE, Johansen M, Ojeaga A, de la Feld S.: Hand Dermatitis in the Time of COVID-19: A Review of Occupational Irritant Contact Dermatitis. Dermatitis 32(2): 86-93, Mar-Apr 2021.
f0 Kersh AE, Schuchter LM, Elenitsas R, Chu EY.: Hypohidrosis as an immune-related adverse event of checkpoint inhibitor therapy. Immunotherapy 12(13): 951-956, Sep 2020.
2c
7
1d
1f
Selected Publications
a1 Kersh, A.E. and Lobo Lopes, J: Trigeminal trophic syndrome. NEJM 394(10): e16, Mar 2026.134 Huang J, Sati S, Murphy C, Spencer CA, Rapp E, Prouty SM, Korte S, Ahart O, Sheng E, Jones P, Kersh AE, Leung D, Leung TH.: Granulocyte colony stimulating factor promotes scarless tissue regeneration. Cell Rep 43(10): 114742, Oct 2024.
100 Kersh AE, Sati S, Huang J, Murphy C, Ahart O, Leung TH.: CXCL9, CXCL10, and CCL19 synergistically recruit T lymphocytes to skin in lichen planus. JCI Insight 9(20): e179899, Oct 2024.
177 Sati S, Huang J, Kersh AE, Jones P, Ahart O, Murphy C, Prouty SM, Hedberg ML, Jain V, Gregory SG, Leung DH, Seykora JT, Rosenbach M, Leung TH.: Recruitment of CXCR4+ type 1 innate lymphoid cells distinguishes sarcoidosis from other skin granulomatous diseases. J Clin Invest 134(17): e178711, Sep 2024.
130 Bhattarcharya, S., Sheng, E., Murphy, C., Wei, J., Kersh, A.E., Nelson, C.A., Aschanyan, H.A., Steele, K., Forrestel, A., Seykora, J.T., Micheletti, R.G., James, W.D., Rosenbach, M., Leung, T.H. : Identification of a neutrophil-specific PIK3R1 mutation 33 facilitates targeted treatment in a patient with 50 Sweet syndrome. J Clin Invest 133(1): e162137, Jan 2023.
199 Bhattacharya S, Basu S, Sheng E, Murphy C, Wei J, Kersh AE, Nelson CA, Bryer JS, Ashchyan HA, Steele K, Forrestel A, Seykora JT, Micheletti RG, James WD, Rosenbach M, Leung TH.: Identification of a neutrophil-specific PIK3R1 mutation facilitates targeted treatment in a patient with Sweet syndrome. J Clin Invest 133: e162137, Jan 2023.
14c Abbott JJ, Jiang AJ, Rauck C, Frank DM, Fortuna D, Kersh A, Rubin AI.: Cutaneous metastatic gastric carcinoma with plasmacytoid features: A novel histopathologic pitfall in the diagnosis of primary cutaneous plasmacytoma. J Cutan Pathol 50(1): 8-11, Jan 2023.
ee Torre EA, Kersh AE, Fischer AS, Xu X, Rosenbach M, Shields BE.: Angiokeratoma-like purpuric palmar nodules following chemotherapy. Dermatol Online J 27(8), Aug 2021.
fd Kersh AE, Johansen M, Ojeaga A, de la Feld S.: Hand Dermatitis in the Time of COVID-19: A Review of Occupational Irritant Contact Dermatitis. Dermatitis 32(2): 86-93, Mar-Apr 2021.
f0 Kersh AE, Schuchter LM, Elenitsas R, Chu EY.: Hypohidrosis as an immune-related adverse event of checkpoint inhibitor therapy. Immunotherapy 12(13): 951-956, Sep 2020.
2c